NYSE · Medical - Specialties

Shoulder Innovations, Inc. (SI) Stock

$18.13 +1.34% NYSE: SI Healthcare

Valuation

MetricValue
Price$18.13
Market Cap$375.98M
P/E Ratio-11.12
P/B Ratio3.17
P/S Ratio6.56
EPS (TTM)$-0.52
52-Week High$24.60
52-Week Low$10.92
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.67%
ROA-23.05%
ROCE-25.26%
Gross Margin-57.45%
Operating Margin-55.32%
Net Margin-58.33%
Debt/Equity0.12
Current Ratio-19.62

Annual Financials (USD)

Metric202320242025
Revenue$19.0M$32.0M$47.0M
Operating Profit$-11.0M$-15.0M$-26.0M
Net Profit$-13.0M$-16.0M$-40.0M
EPS$-0.63$-0.77$-1.96
Op Margin-56.4%-46.3%-55.6%

Balance Sheet (USD)

Metric202320242025
Total Assets$54.0M$43.0M$170.0M
Total Liabilities$94.0M$98.0M$29.0M
Cash$6.0M$6.0M$27.0M
Borrowings$14.0M$15.0M$15.0M

Latest News

Shoulder Innovations to Report Second Quarter 2026 Financial Results on August 6, 2026 PR Newswire · Jul 14, 2026 Shoulder Innovations Closes Up to $50 Million Credit Facility MT Newswires · Jun 29, 2026 Shoulder Innovations Announces Closing of up to $50 Million Credit Facility PR Newswire · Jun 29, 2026 Wall Street Analysts See a 51.79% Upside in Shoulder Innovations, Inc. (SI): Can the Stock Really Move This High? Zacks · Jun 3, 2026 Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire · May 26, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$-13.0M$-14.0M$-29.0M
Investing Cash Flow$-32.0M$10.0M$-103.0M
Financing Cash Flow$0$0$0
Net Cash Flow$3.0M$0$21.0M
Free Cash Flow$-16.0M$-18.0M$-36.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.70
EV / EBITDA-11.65
FCF Yield-11.94%
Quick Ratio8.92
Interest Coverage37.04
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Institutional HolderSharesReport Date
FMR, LLC3,784,5522026-03-31
Blackrock Inc.556,0522026-03-31
Sectoral Asset Management, Inc.430,4072026-03-31
Vanguard Capital Management LLC413,4802026-03-31
Times Square Capital Management, LLC322,7642026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AARDAardvark Therapeutics, Inc. $4.76 +1.06% -1.55 $104.17M 0.00%
ASMBAssembly Biosciences, Inc. $23.53 +3.11% 40.98 $466.30M 0.00%
ENTAEnanta Pharmaceuticals, Inc. $12.50 +3.31% -5.32 $363.48M 0.00%
EPRXEupraxia Pharmaceuticals Inc. $7.46 -1.45% -7.10 $249.76M 0.00%
INGNInogen, Inc $6.18 +4.04% -6.57 $167.32M 0.00%

About Shoulder Innovations, Inc.

Shoulder Innovations, Inc. is led by CEO Alan J. Lane, employs 300 people, headquartered in US, publicly traded since 2025.

Shoulder Innovations, Inc. (SI) stock trades at $18.13 with a market capitalization of $375.98M. The stock is valued at a price-to-earnings (P/E) ratio of -11.12, price-to-book of 3.17, price-to-sales of 6.56. Over the past 52 weeks the stock has ranged between $10.92 and $24.60, and currently trades 26.3% below its 52-week high.

On profitability, Shoulder Innovations, Inc. generates a return on equity (ROE) of -25.67%, return on capital employed of -25.26%, an operating margin of -55.32%, a net profit margin of -58.33%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides